DermTech, Inc. (DMTK)

NASDAQ: DMTK · IEX Real-Time Price · USD
+0.09 (1.63%)
At close: Jun 29, 2022 4:00 PM
+0.36 (6.42%)
After-hours: Jun 29, 2022 7:53 PM EDT

Total Valuation

DermTech has a market cap or net worth of $167.97 million. The enterprise value is -$10.86 million.

Market Cap 167.97M
Enterprise Value -10.86M

Important Dates

The next earnings date is Wednesday, August 3, 2022, after market close.

Estimated Earnings Date Aug 3, 2022
Ex-Dividend Date n/a

Share Statistics

DermTech has 29.94 million shares outstanding. The number of shares has increased by 9.88% in one year.

Shares Outstanding 29.94M
Shares Change (YoY) +9.88%
Shares Change (QoQ) +0.32%
Owned by Insiders (%) 8.24%
Owned by Institutions (%) 79.65%
Float 22.79M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 12.89
PB Ratio 0.83
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.43, with a Debt / Equity ratio of 0.11.

Current Ratio 14.43
Quick Ratio 14.36
Debt / Equity 0.11
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -39.20%, which is considered low. The company has a ROIC of -141.80%.

Return on Equity (ROE) -39.20%
Return on Assets (ROA) -36.10%
Return on Capital (ROIC) -141.80%
Revenue Per Employee $51,106
Profits Per Employee -$366,176
Employee Count 255
Asset Turnover 0.05
Inventory Turnover 23.26


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -86.28% in the last 52 weeks. The beta is 1.40, so DermTech's price volatility has been higher than the market average.

Beta (1Y) 1.40
52-Week Price Change -86.28%
50-Day Moving Average 6.15
200-Day Moving Average 11.49
Average Volume (30 Days) 953,251

Short Selling Information

The latest short interest is 5.28 million, so 17.64% of the outstanding shares have been sold short.

Short Interest 5.28M
Short % of Shares Out 17.64%
Short % of Float 23.17%
Short Ratio (days to cover) 4.98

Income Statement

In the last 12 months, DermTech had revenue of $13.03 million and -93.38 million in losses. Earnings per share was -$3.16.

Revenue 13.03M
Gross Profit 916,000
Operating Income -94.18M
Net Income -93.38M
EBITDA -90.47M
EBIT -93.38M
Earnings Per Share (EPS) -$3.16
Full Income Statement

Balance Sheet

The company has $202.13 million in cash and $23.30 million in debt, giving a net cash position of $178.83 million or $5.97 per share.

Cash & Cash Equivalents 202.13M
Total Debt 23.30M
Net Cash 178.83M
Net Cash Per Share $5.97
Book Value 203.48M
Book Value Per Share 6.80
Working Capital 193.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$76.21 million and capital expenditures -$3.35 million, giving a free cash flow of -$79.57 million.

Operating Cash Flow -76.21M
Capital Expenditures -3.35M
Free Cash Flow -79.57M
FCF Per Share n/a
Full Cash Flow Statement


Gross margin is 7.03%, with operating and profit margins of -722.65% and -716.51%.

Gross Margin 7.03%
Operating Margin -722.65%
Pretax Margin n/a
Profit Margin -716.51%
EBITDA Margin -694.18%
EBIT Margin -716.51%
FCF Margin -610.55%

Dividends & Yields

DermTech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -55.59%
FCF Yield -47.37%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -9.88%
Shareholder Yield -9.88%
Dividend Details

Analyst Forecast

The average price target for DermTech is $30.26, which is 439.39% higher than the current price. The consensus rating is "Buy".

Price Target $30.26
Price Target Difference 439.39%
Analyst Consensus Buy
Analyst Count 13
Stock Forecasts

Stock Splits

The last stock split was on August 30, 2019. It was a reverse split with a ratio of 1:2.

Last Split Date Aug 30, 2019
Split Type Reverse
Split Ratio 1:2